These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26219658)

  • 21. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
    Mo C; Renoir T; Hannan AJ
    Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive training modifies disease symptoms in a mouse model of Huntington's disease.
    Yhnell E; Lelos MJ; Dunnett SB; Brooks SP
    Exp Neurol; 2016 Aug; 282():19-26. PubMed ID: 27163546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
    Giralt A; Puigdellívol M; Carretón O; Paoletti P; Valero J; Parra-Damas A; Saura CA; Alberch J; Ginés S
    Hum Mol Genet; 2012 Mar; 21(6):1203-16. PubMed ID: 22116937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexin II is essential for normal neurological function in mice.
    Glynn D; Bortnick RA; Morton AJ
    Hum Mol Genet; 2003 Oct; 12(19):2431-48. PubMed ID: 12915444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of depression on working memory in presymptomatic Huntington's disease.
    Nehl C; Ready RE; Hamilton J; Paulsen JS
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):342-6. PubMed ID: 11514640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.
    Abada YS; Schreiber R; Ellenbroek B
    Behav Brain Res; 2013 Feb; 238():243-51. PubMed ID: 23123142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Real-life' hippocampal-dependent spatial memory impairments in Huntington's disease.
    Glikmann-Johnston Y; Carmichael AM; Mercieca EC; Stout JC
    Cortex; 2019 Oct; 119():46-60. PubMed ID: 31071556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington's disease mouse line.
    Brooks SP; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):130-6. PubMed ID: 21763407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice.
    Mazarakis NK; Cybulska-Klosowicz A; Grote H; Pang T; Van Dellen A; Kossut M; Blakemore C; Hannan AJ
    J Neurosci; 2005 Mar; 25(12):3059-66. PubMed ID: 15788762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.
    Carter RJ; Lione LA; Humby T; Mangiarini L; Mahal A; Bates GP; Dunnett SB; Morton AJ
    J Neurosci; 1999 Apr; 19(8):3248-57. PubMed ID: 10191337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
    Pallier PN; Drew CJ; Morton AJ
    Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verification of somatic CAG repeat expansion by pre-PCR fractionation.
    Hunter JM; Crouse AB; Lesort M; Johnson GV; Detloff PJ
    J Neurosci Methods; 2005 May; 144(1):11-7. PubMed ID: 15848234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
    Panegyres PK; Goh JG
    J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for specific cognitive deficits in preclinical Huntington's disease.
    Lawrence AD; Hodges JR; Rosser AE; Kershaw A; ffrench-Constant C; Rubinsztein DC; Robbins TW; Sahakian BJ
    Brain; 1998 Jul; 121 ( Pt 7)():1329-41. PubMed ID: 9679784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
    Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
    Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task.
    Leach PT; Hayes J; Pride M; Silverman JL; Crawley JN
    eNeuro; 2016; 3(1):. PubMed ID: 27022628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.